{"id":"W4297989875","doi":"10.1007/s12032-022-01836-3","title":"RETRACTED ARTICLE: Niosomes: a novel targeted drug delivery system for cancer","year":2022,"lang":"en","type":"review","venue":"Medical Oncology","topic":"Advancements in Transdermal Drug Delivery","field":"Pharmacology, Toxicology and Pharmaceutics","cited_by":97,"is_retracted":true,"has_abstract":false,"ca_institutions":"Emergent BioSolutions (Canada)","funders":"","keywords":"Niosome; Nanocarriers; Drug delivery; Drug; Nanotechnology; Pharmacology; Targeted drug delivery; Medicine; Vesicle; Materials science; Chemistry","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":{"nature":"Retraction","reason":"Compromised Peer Review;Investigation by Company/Institution;Investigation by Journal/Publisher;Misconduct - Official Investigation(s) and/or Finding(s);Misconduct by Author;Objections by Author(s);Paper Mill;","date":"3/22/2025 0:00","openalex_flagged":true},"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":["research_integrity"],"consensus_categories":[],"category_scores_codex":[0.002043678,0.0009179631,0.001336478,0.001451296,0.000888924,0.00175902,0.0019752,0.004563479,0.01084364],"category_scores_gemma":[0.004355696,0.0003465531,0.0007381169,0.001375793,0.001272961,0.002765274,0.001902151,0.004053069,0.007218503],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00107401,"about_ca_system_score_gemma":0.003313931,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001790769,"about_ca_topic_score_gemma":0.003438186,"domain_scores_codex":[0.9988384,0.0001392711,0.0001893272,0.0001183102,0.0005623016,0.0001525314],"domain_scores_gemma":[0.9982842,0.0004107393,0.0001973494,0.00006786676,0.0008506585,0.0001892962],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002271226,0.0000653644,0.0002166124,0.005679831,0.00007310657,0.001155336,0.0001750679,0.000174442,0.004568477,0.003890335,0.7190073,0.264767],"study_design_scores_gemma":[0.0000246826,0.0001021047,0.0002452012,0.0004957588,0.00006668689,0.001099764,0.00004712556,0.00007171154,0.002177894,0.000731466,0.9949158,0.00002194265],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"editorial","genre_gemma":"review","genre_scores_codex":[0.003032788,0.4022273,0.003674783,0.07701212,0.5001372,0.0001374404,0.0008584634,0.0003290409,0.01259101],"genre_scores_gemma":[0.02142377,0.5636615,0.005159557,0.1181439,0.1162136,0.0001539677,0.001729246,0.0002563407,0.1732582],"genre_candidate":"review","genre_consensus":null,"teacher_disagreement_score":0.9954365,"threshold_uncertainty_score":0.03627557,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2040673654015406,"score_gpt":0.5081526482652872,"score_spread":0.3040852828637466,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}